Aklilu Lemma Institute of Pathobiology, Addis Ababa University, Addis Ababa, Ethiopia.
BMC Infect Dis. 2010 Dec 17;10:354. doi: 10.1186/1471-2334-10-354.
Currently, T-cell based gamma interferon (IFNγ) release assays (IGRAs) are acknowledged as the best methods available for the screening of latent tuberculosis infection (LTBI) and also as aid for the diagnosis of active tuberculosis (TB). To our information, the performance of these diagnostic tests has not been evaluated in Ethiopia. Therefore, the intent of this study was to evaluate the performance of QuantiFERON-TB Gold In-Tube (QFTGIT) in patients clinically suspected of active pulmonary TB (PTB) as well as in healthy subjects prior to its utilization for the epidemiological study of active TB and LTBI in Afar pastoralists.
The sensitivity of QFTGIT was evaluated in 140 subjects who were clinically suspected of PTB using the cut-off value recommended by the manufacturer (≥ 0.35 IU/ml) and disease-specific cut-off value. Sputum culture result was used as a gold standard. The specificity of the test was evaluated both in patients and in 55 tuberculin skin test (TST) negative healthy subjects.
Out of the 140 study participants, 37 (26.4%) were positive for active PTB by culture. Out of the 37 subjects who had positive results by culture, 6 individuals were HIV-seropositive. Out of the 103 subjects who were negative by culture, 6 subjects had indeterminate results and 21 were HIV-seropositive. The performance of the test was assessed using data from 107 (31 culture positive and 76 culture negative) individuals who were clinically suspected of PTB and HIV-seronegatives. Using the manufacturer recommended cut-off value, the sensitivity of the test was 64.5% (20/31), while its specificity was 36.8% (28/76). The sensitivity of the test was increased to 77.4%, while the specificity was reduced to 23.7% using a cut-off value ≥ 0.1 IU/ml of IFNγ as disease-specific cut-off value. In TST negative healthy subjects, the specificity of the test was 58.2%.
Our findings revealed a low sensitivity of QFTGIT in the diagnosis of Mycobacterium tuberculosis (Mtb) infection in the present study area using the cut-off value recommended by the manufacturer. Nevertheless, the sensitivity increased from 64.5% to 77.4% by lowering the cut-off value recommended by the manufacturer to ≥ 0.1 IU/ml of IFNγ level. Hence, it is of practical importance to evaluate the performance of QFTGIT in population under different settings prior to its application either for the diagnosis of active TB or LTBI.
目前,T 细胞γ干扰素(IFNγ)释放试验(IGRAs)被认为是筛查潜伏性结核感染(LTBI)和辅助诊断活动性结核(TB)的最佳方法。据我们所知,这些诊断检测的性能尚未在埃塞俄比亚进行评估。因此,本研究的目的是评估 QuantiFERON-TB Gold In-Tube(QFTGIT)在临床疑似活动性肺结核(PTB)患者中的性能,以及在用于 Afar 牧民活动性 TB 和 LTBI 流行病学研究之前在健康受试者中的性能。
使用制造商推荐的(≥0.35IU/ml)和疾病特异性截断值评估 QFTGIT 在 140 名临床疑似 PTB 患者中的敏感性。痰培养结果为金标准。在患者和 55 名结核菌素皮肤试验(TST)阴性的健康受试者中评估了该检测的特异性。
在 140 名研究参与者中,37 名(26.4%)培养阳性的患者患有活动性 PTB。在 37 名培养阳性的患者中,有 6 名 HIV 血清阳性。在 103 名培养阴性的患者中,有 6 名患者的结果不确定,有 21 名 HIV 血清阳性。使用来自 107 名(31 名培养阳性和 76 名培养阴性)临床疑似 PTB 和 HIV 血清阴性患者的数据评估了该检测的性能。使用制造商推荐的截断值,该检测的敏感性为 64.5%(20/31),特异性为 36.8%(28/76)。当使用≥0.1IU/ml IFNγ作为疾病特异性截断值的截断值时,检测的敏感性增加到 77.4%,而特异性降低到 23.7%。在 TST 阴性的健康受试者中,该检测的特异性为 58.2%。
本研究结果显示,在使用制造商推荐的截断值时,QFTGIT 在本研究地区诊断结核分枝杆菌(Mtb)感染的敏感性较低。然而,通过将制造商推荐的截断值降低至≥0.1IU/ml IFNγ水平,敏感性从 64.5%增加到 77.4%。因此,在将 QFTGIT 应用于诊断活动性 TB 或 LTBI 之前,在不同人群中评估其性能具有重要的实际意义。